Is seratiopeptidase safe in patient with seizure disorder
Reading File
Finding Sources
Searching PubMed
serratiopeptidase AND safety
Searching the Web
serratiopeptidase safety drug interactions seizure disorder antiepileptic official information
Seratiopeptidase (serrapeptase) is not known to lower the seizure threshold or to have a specific contraindication in seizure disorders. There is also no well-established interaction with common antiseizure medicines.
However, its overall safety and drug-interaction evidence is limited, and formulations vary. It should be used only after the prescriber/pharmacist reviews the exact product and current antiseizure drug regimen, especially if the patient takes multiple medicines.
Key cautions:
- Avoid or seek advice if taking anticoagulants, antiplatelet drugs, or NSAIDs, because serratiopeptidase may increase bleeding/bruising risk.
- Stop and seek care for rash, facial swelling, breathing difficulty, unexplained bleeding, or severe gastrointestinal symptoms.
- If seizures become more frequent or there is any new neurologic symptom after starting it, stop it and contact the treating clinician promptly.
The published review literature describes generally infrequent adverse effects but emphasizes that high-quality controlled safety data are insufficient, including for drug combinations and special populations (review of serratiopeptidase safety). No relevant recent systematic review specifically addressing seizure disorders was identified.
This is a shared conversation. Sign in to Orris to start your own chat.